These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25474636)

  • 21. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity.
    Vakili A; Mousavi Gargari SL; Nazarian S; Amani J
    Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion-expressed CtxB-TcpA-C-CPE improves both systemic and mucosal humoral and T-cell responses against cholera in mice.
    Souod N; Kargar M; Hoseini MH; Jafarinia M
    Microb Pathog; 2021 Aug; 157():104978. PubMed ID: 34022352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.
    Albert MJ; Mustafa AS; Islam A; Haridas S
    mBio; 2013 May; 4(3):e00246-13. PubMed ID: 23653448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model.
    Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S
    Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
    Sayeed MA; Bufano MK; Xu P; Eckhoff G; Charles RC; Alam MM; Sultana T; Rashu MR; Berger A; Gonzalez-Escobedo G; Mandlik A; Bhuiyan TR; Leung DT; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
    PLoS Negl Trop Dis; 2015; 9(7):e0003881. PubMed ID: 26154421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.
    Anvari S; Najar-Peerayeh S; Behmanesh M; Bakhshi B
    Hum Vaccin Immunother; 2018; 14(9):2323-2328. PubMed ID: 29852089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.
    Voss E; Manning PA; Attridge SR
    Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant cholera toxin B subunit and gene fusion proteins for oral vaccination.
    Sanchez J; Johansson S; Löwenadler B; Svennerholm AM; Holmgren J
    Res Microbiol; 1990; 141(7-8):971-9. PubMed ID: 2101488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the cholera toxin B subunit (CT-B) in maize seeds and a combined mucosal treatment against cholera and traveler's diarrhea.
    Karaman S; Cunnick J; Wang K
    Plant Cell Rep; 2012 Mar; 31(3):527-37. PubMed ID: 21938449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
    Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
    Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.
    Davoodi-Semiromi A; Schreiber M; Nalapalli S; Verma D; Singh ND; Banks RK; Chakrabarti D; Daniell H
    Plant Biotechnol J; 2010 Feb; 8(2):223-42. PubMed ID: 20051036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.
    Sun DX; Mekalanos JJ; Taylor RK
    J Infect Dis; 1990 Jun; 161(6):1231-6. PubMed ID: 1971653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.
    Harris AM; Bhuiyan MS; Chowdhury F; Khan AI; Hossain A; Kendall EA; Rahman A; LaRocque RC; Wrammert J; Ryan ET; Qadri F; Calderwood SB; Harris JB
    Infect Immun; 2009 Sep; 77(9):3850-6. PubMed ID: 19528207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.
    Chowdhury F; Khan AI; Harris JB; LaRocque RC; Chowdhury MI; Ryan ET; Faruque AS; Calderwood SB; Qadri F
    Pediatr Infect Dis J; 2008 Nov; 27(11):986-92. PubMed ID: 18833030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of Chicken Egg Yolk Antibody (IgY) Against Recombinant Cholera Toxin B Subunit and Evaluation of Its Prophylaxis Potency in Mice.
    Barati B; Ebrahimi F; Nazarian S
    Iran J Immunol; 2018 Mar; 15(1):47-58. PubMed ID: 29549232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
    Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
    Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
    Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
    Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal stability of an oral killed-cholera-whole-cell vaccine containing recombinant B-subunit of cholera toxin.
    Ahmed ZU; Hoque MM; Rahman AS; Sack RB
    Microbiol Immunol; 1994; 38(11):837-42. PubMed ID: 7898381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
    Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
    Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.